SEC Form 4 · accession 0001209191-18-023572
MAGELLAN HEALTH INC · MGLN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mostafa Kamal
Officer — CEO, Magellan Rx Management
Period of report
Apr 2, 2018
Accepted (ET)
Apr 4, 2018 · 3:47 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000019411
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Common Stock, $0.01 par value | Apr 2, 2018 | X | 1,666 | $71.00 | A | 1,666 | D | |
| Ordinary Common Stock, $0.01 par value | Apr 2, 2018 | S | 1,666 | $106.20 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F3,F2 | $71.00 | Apr 2, 2018 | X | 1,666 | D | — | Apr 1, 2025 | Common Stock | 1,666 | 0 | D |
Explanation of responses
- F1This transaction was effectuated pursuant to a Rule 10b-5-1 Plan.
- F2All of the stock options in this tranche have vested in full.
- F3Not applicable.